DOCSLIB.ORG

Pathways , and IL-15 Β

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pathways , and IL-15 Β Published August 14, 2015, doi:10.4049/jimmunol.1500325 The Journal of Immunology Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1b, IFN-b, and IL-15 Pathways Irene Mattiola,*,†,‡,1 Matthieu Pesant,*,1 Paolo F. Tentorio,† Martina Molgora,*,‡ Emanuela Marcenaro,x Enrico Lugli,† Massimo Locati,*,‡,2 and Domenico Mavilio†,‡,2 The cross talk between NK cells and macrophages is emerging as a major line of defense against microbial infections and tumors. This study reveals a complex network of soluble mediators and cell-to-cell interactions allowing human classically activated (M1) macrophages, but not resting (M0) or alternatively activated (M2) macrophages, to prime resting autologous NK cells. In this article, we show that M1 increase NK cell cytotoxicity by IL-23 and IFN-b–dependent upregulation of NKG2D, IL-1b–dependent upreg- ulation of NKp44, and trans-presentation of IL-15. Moreover, both IFN-b–dependent cis-presentation of IL-15 on NK cells and engagement of the 2B4-CD48 pathway are used by M1 to trigger NK cell production of IFN-g. The disclosure of these synergic cellular mechanisms regulating the M1–NK cell cross talk provides novel insights to better understand the role of innate immune responses in the physiopathology of tumor biology and microbial infections. The Journal of Immunology, 2015, 195: 000–000. atural killer cells are important components of the in- the heterogeneous family of inhibitory NK cell receptors and nate immune system and play an active role in the clear- MHC class I molecules allow the NK cell–mediated killing via the N ance of tumor-transformed and viral-infected cells either engagement of a large group of activating NKRs (aNKRs) that bind lacking or down-modulating molecules of the MHC class I without specific ligands expressed on stressed (i.e., infected by pathogens, a prior sensitization (1). Impairments of the interactions between transplanted, inflamed) or tumor-transformed cells (2–4). Upon activation, NK cells also secrete a variety of proinflammatory cytokines and chemokines, which play important regulatory func- *Leukocyte Biology Unit, Humanitas Clinical and Research Center, I-20089 Roz- tions in the context of immune responses, hematopoiesis, and cel- † zano, Milan, Italy; Unit of Clinical and Experimental Immunology, Humanitas lular homeostasis (1, 5). Clinical and Research Center, I-20089 Rozzano, Milan, Italy; ‡Department of Med- ical Biotechnologies and Translational Medicine, University of Milan, I-20089 Roz- Macrophages are well-known for being important players in zano, Milan, Italy; and xDipartimento di Medicina Sperimentale and Centro di the physiopathology of microbial infections and cancer. In line with Eccellenza per le Ricerche Biomediche, Universita` degli Studi di Genova, I-16132 the Th1/Th2 T cell polarization, the stimulation of resting macro- Genoa, Italy phages (M0) with Th1 cytokines (i.e., IFN-g) and the TLR4 ligands 1I.M. and M.P. contributed equally to this work. 2 (i.e., LPS) induces the classical polarization toward M1 macro- M.L. and D.M. are joint senior authors on this work. phages (M1), which display strong microbicidal and tumoricidal ORCIDs: 0000-0003-3077-590X (M.L.); 0000-0001-6147-0952 (D.M.). activities and preferentially promote inflammatory responses. In Received for publication February 11, 2015. Accepted for publication July 19, 2015. contrast, the alternative polarization toward M2 macrophages (M2) This work was supported by Italian Ministry of Health (Bando Giovani Ricercatori) is induced by the Th2 cytokine IL-4 (6, 7). M2 are involved in the Grant GR-2008-1135082 (to D.M.), a Ministry of University and Research Fondo per gli Investimenti della Ricerca di Base “Futuro in Ricerca” project (to M.L.), Italian control of parasite infections and in tissue remodeling and fi- Association for Cancer Research Grants IG 9104 and 14687 (to D.M.) and IG 14685 brosis, and they are endowed with potent proangiogenic features (to M.L.), European Union Marie Curie International Reintegration Grant 322093 (to that favor tumor progression by virtue of their immunoregulatory E.L.) and Collaborative Project TIMER-HEALTH-F4-2011-281608 (to M.L.), the intramural research program of Humanitas Clinical and Research Center (to D.M.), functions (8, 9). The different biological properties of M1 and a European School of Molecular Medicine/Structured International Postdoctoral M2 are also mirrored by distinctive cytokine and chemokine rep- Marie Curie International Mobility Fellowship (to M.P.), and a “Mario e Valeria ertoires (10). Tumor-associated macrophages (TAMs), present in Rindi” Fellowship from the Italian Foundation for Cancer Research (to I.M.). solid tumors at high frequency, display both proangiogenic and I.M., M.P., M.L., and D.M. conceived and designed the experiments; I.M., M.P., P.F.T., M.M., and E.L. performed the experiments; I.M. and M.P. analyzed the data; immune-regulatory features resembling the M2 phenotype (11). It E.M. provided reagents; and I.M., M.P., M.L., and D.M. wrote the manuscript. is now widely accepted that TAMs sustain cancer growth by en- Address correspondence and reprint requests to Prof. Massimo Locati or Prof. Do- gaging vicious cellular cross talks with malignant cells and other menico Mavilio, Leukocyte Biology Unit, Department of Medical Biotechnologies immune effectors within the tumor mass, thus worsening clinical and Translational Medicine, University of Milan School of Medicine, Humanitas Clinical and Research Center, Via Alessandro Manzoni 113, I-20089 Rozzano, Mi- prognosis and favoring disease progression (12–14). lan, Italy (M.L.) or Clinical and Experimental Immunology Unit, Department of Over the past decade, several lines of evidence clearly demon- Medical Biotechnologies and Translational Medicine, University of Milan School strated that NK cells are able to engage bidirectional interactions of Medicine, Humanitas Clinical and Research Center, Via Alessandro Manzoni 113, I-20089 Rozzano, Milan, Italy (D.M.). E-mail addresses: massimo.locati@ with other members of innate immunity, such as autologous den- unimi.it (M.L.) or [email protected] (D.M.) dritic cells (DCs), macrophages, and neutrophils (2, 15–20). The The online version of this article contains supplemental material. final outcome of these synergic interactions mediated by both cell- Abbreviations used in this article: aNKR, activating NKR; DC, dendritic cell; ILC, to-cell contacts and soluble mediators is the coordination and innate lymphoid cell; IL-15Ra, IL-15R a-chain; rh, recombinant human; RT, room optimization of both innate and adaptive immune responses. In temperature; TAM, tumor-associated macrophage. particular, the NK cell–macrophage cross talk is highly relevant Copyright Ó 2015 by The American Association of Immunologists, Inc. 0022-1767/15/$25.00 in the context of host–pathogen interactions (15, 16, 19) and www.jimmunol.org/cgi/doi/10.4049/jimmunol.1500325 2 PRIMING OF NK CELLS BY AUTOLOGOUS M1 MACROPHAGES during the course of viral infections (20). However, the mechanism(s) Flow cytometry and cell sorting adopted by activated human macrophages to regulate autologous For direct multicolor flow-cytometry analysis (FACSCanto II; BD Bio- resting NK cell functions are largely unknown. A proper activation sciences) or cell sorting (FACSAria II; BD Biosciences), NK cells, mono- of NK cells can be achieved with different proinflammatory cyto- cytes, and polarized macrophages were washed with HBSS (Lonza) kines, such as IL-2, IL-12, IL-15, IL-18, and type I IFNs (1, 21, 22). supplemented with 2% FBS and incubated for 20 min at 4˚C with the In particular, IL-15 has been shown to play an important role in the following directly conjugated Abs labeled with indicated fluorochromes: CD3/CD56-FITC/PC5 (Beckman Coulter), CD3-FITC (BD Pharmingen), context of NK development, homeostasis, and functions. After its CD3-Brilliant Violet 650 (Biolegend), CD14-FITC (BD Pharmingen), CD14- binding to the high-affinity IL-15R a-chain (IL-15Ra) expressed Brilliant Violet 570 (Biolegend), CD16-PE-Cy7 (BD Pharmingen), CD16- by DCs and monocytes/macrophages, IL-15 is trans-presented to PerCP-Cy5.5 (BD Pharmingen), CD19-allophycocyanin-Cy7 (BD Pharmingen), surrounding cells bearing the lower-affinity IL-15Rbg-chains (22, CD48-PE (BD Pharmingen), CD56-Brilliant Violet 421 (Biolegend), CD69- Pe-Cy7 (BD Pharmingen), CD80-PE (BD Pharmingen), CD117-PE-Cy7 23). The membrane-associated IL-15–IL-15Ra complex can be (Biolegend), CD127-PE-Cy5 (eBioscience), CD206-FITC (BD Pharmingen), also cleaved from cell surface and released in biologic fluids, such CD209-PE (BD Pharmingen), M-DC8-allophycocyanin (Miltenyi), NKp46- as plasma (24, 25). More recently, it emerged that IL-15 can also PE (Beckman Coulter), NKp44-PE (Beckman Coulter), NKp30-PE (Beckman be presented by IL-15Ra to IL-15Rbg-chains expressed on the Coulter), NKG2D-PE (Beckman Coulter), DNAM-1–PE (Beckman Coulter), same cell, thus allowing a mechanism of IL-15 cis-presentation that 2B4-PE (R&D Systems), IL-15Ra–PE (Biolegend), IL-1RII–PE (R&D Sys- tems), and their appropriate isotype controls. For IL-1RI indirect staining, triggers NK cell effector functions (26). Another potent proin- NK cells were incubated for 45 min at room temperature (RT) with purified flammatory cytokine produced by M1 is IL-1b, which has been goat anti-human IL-1RI (R&D Systems) or its polyclonal IgG control and reported to modulate homeostasis and activation of innate lym- for 30 min at RT with mouse anti-goat Alexa Fluor 647–labeled sec- phoid cells (ILCs) in secondary lymphoid tissues (27–29). ILCs ondary Ab (Invitrogen). For sorting experiments, thawed NK cells were stained for 15 min at RTwith LIVE/DEAD Aqua (Invitrogen), followed have been recently identified as an additional lymphocytic pop- by incubation for 20 min at RT with fluorochrome-conjugated Abs and ulation that could be divided in different subsets (ILC1, ILC2, then sorted.
Load more

Recommended publications
  • T Cell Binding to Activated Dendritic Cells Cutting Edge
    Cutting Edge: CCR4 Mediates Antigen-Primed T Cell Binding to Activated Dendritic Cells Meng-tse Wu, Hui Fang and Sam T. Hwang This information is current as J Immunol 2001; 167:4791-4795; ; of September 27, 2021. doi: 10.4049/jimmunol.167.9.4791 http://www.jimmunol.org/content/167/9/4791 Supplementary http://www.jimmunol.org/content/suppl/2001/10/11/167.9.4791.DC1 Downloaded from Material References This article cites 32 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/167/9/4791.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2001 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. ● Cutting Edge: CCR4 Mediates Antigen-Primed T Cell Binding to Activated Dendritic Cells Meng-tse Wu, Hui Fang, and Sam T. Hwang1 DC. In the periphery, activated, Ag-bearing DC may bind to cog- The binding of a T cell to an Ag-laden dendritic cell (DC) is a nate effector memory T cells (mTC).
    [Show full text]
  • Type I Interferons and the Development of Impaired Vascular Function and Repair in Human and Murine Lupus
    Type I Interferons and the Development of Impaired Vascular Function and Repair in Human and Murine Lupus by Seth G Thacker A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Immunology) in The University of Michigan 2011 Doctoral Committee: Associate Professor Mariana J. Kaplan, Chair Professor David A. Fox Professor Alisa E. Koch Professor Matthias Kretzler Professor Nicholas W. Lukacs Associate Professor Daniel T. Eitzman © Seth G Thacker 2011 Sharon, this work is dedicated to you. This achievement is as much yours as it is mine. Your support through all six years of this Ph.D. process has been incredible. You put up with my countless miscalculations on when I would finish experiments, and still managed to make me and our kids feel loved and special. Without you this would have no meaning. Sharon, you are the safe harbor in my life. ii Acknowledgments I have been exceptionally fortunate in my time here at the University of Michigan. I have been able to interact with so many supportive people over the years. I would like to express my thanks and admiration for my mentor. Mariana has taught me so much about writing, experimental design and being a successful scientist in general. I could never have made it here without her help. I would also like to thank Mike Denny. He had a hand in the beginning of all of my projects in one way or another, and was always quick and eager to help in whatever way he could. He really made my first year in the lab successful.
    [Show full text]
  • Mechanism of Macrophage-Derived Chemokine/CCL22 Production by Hacat Keratinocytes
    C Yano, et al Ann Dermatol Vol. 27, No. 2, 2015 http://dx.doi.org/10.5021/ad.2015.27.2.152 ORIGINAL ARTICLE Mechanism of Macrophage-Derived Chemokine/CCL22 Production by HaCaT Keratinocytes Chizuko Yano, Hidehisa Saeki1, Mayumi Komine2, Shinji Kagami3, Yuichiro Tsunemi4, Mamitaro Ohtsuki2, Hidemi Nakagawa Department of Dermatology, The Jikei University School of Medicine, 1Department of Dermatology, Nippon Medical School, Tokyo, 2Department of Dermatology, Jichi Medical University, Shimotsuke, 3Department of Dermatology, Kanto Central Hospital, 4Department of Dermatology, Tokyo Women’s Medical University, Tokyo, Japan Background: CC chemokine ligand 17 (CCL17) and CCL22 27(2) 152∼156, 2015) are the functional ligands for CCR4. We previously reported that inhibitors of nuclear factor-kappa B and p38 mi- -Keywords- togen-activated protein kinase (p38 MAPK), but not of ex- Chemokine CCL22, Chemokine CCL17, Epidermal growth tracellular signal-related kinase (ERK), inhibited tumor ne- factor receptor, HaCaT keratinocytes crosis factor (TNF)-α- and interferon (IFN)-γ-induced pro- duction of CCL17 by the human keratinocyte cell line, HaCaT. Further, an inhibitor of epidermal growth factor re- INTRODUCTION ceptor (EGFR) enhanced the CCL17 production by these keratinocytes. Objective: To identify the mechanism under- The macrophage-derived chemokine (MDC)/CC chemo- lying CCL22 production by HaCaT cells. Methods: We inves- kine ligand 22 (CCL22) is one of the functional ligands for tigated the signal transduction pathways by which TNF-α CC chemokine receptor 4 (CCR4) and is a chemoattractant and IFN-γ stimulate HaCaT cells to produce CCL22 by add- for the CCR4-expressing cells such as Th2 cells. We and ing various inhibitors.
    [Show full text]
  • Differential Expression of Interferon-Γ and Chemokine Genes
    Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response Owens et al. Owens et al. Journal of Neuroinflammation 2013, 10:56 http://www.jneuroinflammation.com/content/10/1/56 Owens et al. Journal of Neuroinflammation 2013, 10:56 JOURNAL OF http://www.jneuroinflammation.com/content/10/1/56 NEUROINFLAMMATION RESEARCH Open Access Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response Geoffrey C Owens1,7*, My N Huynh1, Julia W Chang1, David L McArthur1, Michelle J Hickey2, Harry V Vinters2,3, Gary W Mathern1,4,5,6† and Carol A Kruse1,6† Abstract Background: Rasmussen encephalitis (RE) is a rare complex inflammatory disease, primarily seen in young children, that is characterized by severe partial seizures and brain atrophy. Surgery is currently the only effective treatment option. To identify genes specifically associated with the immunopathology in RE, RNA transcripts of genes involved in inflammation and autoimmunity were measured in brain tissue from RE surgeries and compared with those in surgical specimens of cortical dysplasia (CD), a major cause of intractable pediatric epilepsy. Methods: Quantitative polymerase chain reactions measured the relative expression of 84 genes related to inflammation and autoimmunity in 12 RE specimens and in the reference group of 12 CD surgical specimens. Data were analyzed by consensus clustering using the entire dataset, and by pairwise comparison of gene expression levels between the RE and CD cohorts using the Harrell-Davis distribution-free quantile estimator method.
    [Show full text]
  • The Combination of IL-12 and IL-18 NK/T-NK Cells Derived with IL-2, IL-15
    Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-18 This information is current as Bernard R. Lauwerys, Nathalie Garot, Jean-Christophe of September 28, 2021. Renauld and Frédéric A. Houssiau J Immunol 2000; 165:1847-1853; ; doi: 10.4049/jimmunol.165.4.1847 http://www.jimmunol.org/content/165/4/1847 Downloaded from References This article cites 31 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/165/4/1847.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-181 Bernard R. Lauwerys,* Nathalie Garot,* Jean-Christophe Renauld,†‡ and Fre´de´ric A.
    [Show full text]
  • Interleukin-18 in Health and Disease
    International Journal of Molecular Sciences Review Interleukin-18 in Health and Disease Koubun Yasuda 1 , Kenji Nakanishi 1,* and Hiroko Tsutsui 2 1 Department of Immunology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan; [email protected] 2 Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-798-45-6573 Received: 21 December 2018; Accepted: 29 January 2019; Published: 2 February 2019 Abstract: Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. Therefore, IL-12 is a commitment factor that induces the development of Th1 cells. In contrast, IL-18 is a proinflammatory cytokine that facilitates type 1 responses. However, IL-18 without IL-12 but with IL-2, stimulates NK cells, CD4+ NKT cells, and established Th1 cells, to produce IL-3, IL-9, and IL-13. Furthermore, together with IL-3, IL-18 stimulates mast cells and basophils to produce IL-4, IL-13, and chemical mediators such as histamine. Therefore, IL-18 is a cytokine that stimulates various cell types and has pleiotropic functions. IL-18 is a member of the IL-1 family of cytokines. IL-18 demonstrates a unique function by binding to a specific receptor expressed on various types of cells.
    [Show full text]
  • BAFF Suppresses IL-15 Expression in B Cells
    BAFF Suppresses IL-15 Expression in B Cells Ning Ma, Chen Xing, He Xiao, Youdi He, Gencheng Han, Guojiang Chen, Chunmei Hou, Bernadette Marrero, Yujuan Wang, Shengquan Zhang, Beifen Shen, Yan Li and Renxi This information is current as Wang of September 28, 2021. J Immunol 2014; 192:4192-4201; Prepublished online 26 March 2014; doi: 10.4049/jimmunol.1302132 http://www.jimmunol.org/content/192/9/4192 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2014/03/26/jimmunol.130213 Material 2.DCSupplemental http://www.jimmunol.org/ References This article cites 39 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/192/9/4192.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 28, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology BAFF Suppresses IL-15 Expression in B Cells Ning Ma,*,†,1 Chen Xing,*,1 He Xiao,*,1 Youdi He,‡ Gencheng Han,* Guojiang Chen,* Chunmei Hou,* Bernadette Marrero,x Yujuan Wang,{ Shengquan Zhang,‖ Beifen Shen,* Yan Li,* and Renxi Wang* Clinical trials have shown that BAFF inhibitors do not reduce memory B cell levels but can reduce the number of mature B cells.
    [Show full text]
  • Evolutionary Divergence and Functions of the Human Interleukin (IL) Gene Family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W
    UPDATE ON GENE COMPLETIONS AND ANNOTATIONS Evolutionary divergence and functions of the human interleukin (IL) gene family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W. Nebert3* and Vasilis Vasiliou1 1Molecular Toxicology and Environmental Health Sciences Program, Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO 80045, USA 2Department of Clinical Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA 3Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267–0056, USA *Correspondence to: Tel: þ1 513 821 4664; Fax: þ1 513 558 0925; E-mail: [email protected]; [email protected] Date received (in revised form): 22nd September 2010 Abstract Cytokines play a very important role in nearly all aspects of inflammation and immunity. The term ‘interleukin’ (IL) has been used to describe a group of cytokines with complex immunomodulatory functions — including cell proliferation, maturation, migration and adhesion. These cytokines also play an important role in immune cell differentiation and activation. Determining the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response. ILs can also have pro- and anti-inflammatory effects, further complicating their characterisation. These molecules are under constant pressure to evolve due to continual competition between the host’s immune system and infecting organisms; as such, ILs have undergone significant evolution. This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organisation. Within the literature there are a number of overlapping nomenclature and classification systems derived from biological function, receptor-binding properties and originating cell type.
    [Show full text]
  • Plasma Macrophage-Derived Chemokine (CCL22) and Its
    Egypt J Pediatr Allergy Immunol 2005; 3(1): 20-31. Original article Plasma macrophage-derived chemokine (CCL22) and its receptor CCR4 on peripheral blood T lymphocytes of asthmatic children Background: The macrophage-derived chemokine (MDC/CCL22) acts on Mohamed H. Ezzat, CC chemokine receptor-4 (CCR4) to direct trafficking and recruitment of T Karim Y. Shaheen*. helper-2 (TH2) cells into sites of allergic inflammation. It was previously found overexpressed in lesional samples from adult asthmatics. Objective: This study is aimed to investigate the participation of CCR4/MDC axis in the development of TH2-dominated allergen-induced From the Departments childhood asthma in relation to disease activity, attack severity, and of Pediatrics and response to therapy, and to outline its value in differentiating atopic asthma Clinical Pathology*, from infection-associated airway reactivity. Faculty of Medicine, Methods: Proportion of CCR4-expressing peripheral blood T lymphocytes Ain Shams University, + (CCR4 PBTL%) were purified and quantitated by negative selection from Cairo, Egypt. peripheral blood mononuclear cells by flow cytometry, and the concentration of MDC in plasma was measured by ELISA in 32 children with atopic asthma (during exacerbation and remission), as well as in 12 children with acute lower respiratory tract infections (ALRTI), and 20 healthy children serving as controls. Results: The mean plasma MDC level (925±471.5 pg/ml) and CCR4+PBTL% (55.3±23.6%) were significantly higher in asthmatic children during acute attacks in comparison to children with ALRTI (109±27.3 pg/ml and 27.6±7.5%) and healthy controls (99.6±25.6 pg/ml and 24.2±4.1%).
    [Show full text]
  • The Efficacy of Etanercept As Anti-Breast Cancer Treatment Is
    Shirmohammadi et al. BMC Cancer (2020) 20:836 https://doi.org/10.1186/s12885-020-07228-y RESEARCH ARTICLE Open Access The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages Elnaz Shirmohammadi1, Seyed-Esmaeil Sadat Ebrahimi1, Amir Farshchi2 and Mona Salimi3* Abstract Background: Interaction between microenvironment and breast cancer cells often is not considered at the early stages of drug development leading to failure of many drugs at later clinical stages. Etanercept is a TNF-alpha inhibitor that has been investigated for potential antitumor effect in breast cancer with conflicting results. Methods: Secretome data on MDA-MB-231 cancer cell-line were from public repositories and subjected to gene enrichment analyses. Since MDA-MB-231 cells secrete high levels of Granulocyte-Monocyte Colony Stimulating Factor, which activates macrophages to promote tumor growth, the effect of macrophage co-culturing on anticancer efficacy of Etanercept in breast cancer was evaluated using the Boolean network modeling and in vitro experiments including invasion, cell cycle, Annexin PI, and tetrazolium based viability assays and NFKB activity. Results: The secretome profile of MDA-MB-231 cells was similar to the expression of genes following treatment of breast cancer cells with TNF-α. Accordingly, inhibition of TNF-α by Etanercept decreased MDA-MB-231 cell survival, induced apoptosis and cell cycle arrest in vitro and inhibited NFKB activation. The inhibitory effect of Etanercept on cell viability, cell cycle progression, invasion and induction of apoptosis decreased following co-culturing of the cancer cells with macrophages. The Boolean network modeling of the changes in the dynamics of intracellular signaling pathways revealed NFKB activation by secretome of macrophages, leading to a decreased efficacy of Etanercept, suggesting NFKB inhibition as an alternative approach to inhibit cancer cell growth in the presence of macrophage crosstalk.
    [Show full text]
  • Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration
    Published OnlineFirst October 2, 2015; DOI: 10.1158/0008-5472.CAN-14-3499 Cancer Microenvironment and Immunology Research Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression David Anz1,2, Moritz Rapp1, Stephan Eiber1,2, Viktor H. Koelzer1, Raffael Thaler1, Sascha Haubner1, Max Knott1, Sarah Nagel1, Michaela Golic1, Gabriela M. Wiedemann1, Franz Bauernfeind3, Cornelia Wurzenberger1, Veit Hornung3,4, Christoph Scholz5, Doris Mayr6, Simon Rothenfusser1, Stefan Endres1, and Carole Bourquin1,7 Abstract The chemokine CCL22 is abundantly expressed in many tion. Mechanistic investigations indicated that Treg blockade types of cancer and is instrumental for intratumoral recruit- was a consequence of reduced intratumoral CCL22 levels ment of regulatory T cells (Treg), an important subset of caused by type I IFN. Notably, stable expression of CCL22 immunosuppressive and tumor-promoting lymphocytes. In abrogated the antitumor effects of treatment with RLR or this study, we offer evidence for a generalized strategy to TLR ligands. Taken together, our findings argue that type I blunt Treg activity that can limit immune escape and promote IFN blocks the Treg-attracting chemokine CCL22 and thus tumor rejection. Activation of innate immunity with Toll-like helps limit the recruitment of Treg to tumors, a finding with receptor (TLR) or RIG-I–like receptor (RLR) ligands prevented implications for cancer immunotherapy. Cancer Res; 75(21); 1– accumulation of Treg in tumors by blocking their immigra- 11. Ó2015 AACR. Introduction effector T-cell function ex vivo (1). Indeed, suppression of anti- cancer immunity is mediated predominantly by intratumoral Treg The chemokine CCL22 is abundantly expressed in the tissue of that suppress CD8 T-cell responses locally at the tumor site (6).
    [Show full text]
  • HIV-1-Suppressive Factors Are Secreted by CD4 T Cells During
    HIV-1-suppressive factors are secreted by CD4؉ T cells during primary immune responses Sayed F. Abdelwahab*†, Fiorenza Cocchi*†, Kenneth C. Bagley*‡, Roberta Kamin-Lewis*†, Robert C. Gallo*†, Anthony DeVico*†, and George K. Lewis*†§ *Institute of Human Virology, University of Maryland Biotechnology Institute, and Departments of †Microbiology and Immunology and ‡Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201 Contributed by Robert C. Gallo, August 8, 2003 CD4؉ T cells are required for immunity against many viral infec- system faithfully mimics the early stages of the antigen-specific tions, including HIV-1 where a positive correlation has been ob- response of naı¨ve human CD4ϩ T cells, including clonal activa- served between strong recall responses and low HIV-1 viral loads. tion, expansion, contraction, and maintenance (unpublished Some HIV-1-specific CD4؉ T cells are preferentially infected with work and ref. 18). We used this system to study the kinetics of HIV-1, whereas others escape infection by unknown mechanisms. production of HIV-1-suppressive factors against both CXCR4 One possibility is that some CD4؉ T cells are protected from (X4) and CCR5 (R5) viruses. CD4ϩ T cells, starting as naı¨ve cells infection by the secretion of soluble HIV-suppressive factors, al- and differentiating in response to different antigens, secreted though it is not known whether these factors are produced during factors that inhibited both HIV-1IIIB (X4) and HIV-1BaL (R5). primary antigen-specific responses. Here, we show that soluble The anti-X4 factor is predominantly the CC chemokine CCL22 suppressive factors are produced against CXCR4 and CCR5 isolates (macrophage-derived chemokine), whereas the anti-R5 factors -of HIV-1 during the primary immune response of human CD4؉ T are CCL3 (macrophage inflammatory protein-1␣), CCL4 (mac cells.
    [Show full text]